Showing results (861-870 of 1,006) with videos related to

Sort By:
Pageof 101
BMJ Oncology|January 31, 2025
Implications of hormonal carcinogenesis for transgender and gender-diverse people undergoing gender-affirming hormone therapy: an up-to-date reviewAlberto Giovanni Leone, Stefania Bonadonna, Chiara Cassani, et al.
Brain Stimulation|October 13, 2022
Multi-modal investigation of transcranial ultrasound-induced neuroplasticity of the human motor cortexNardin Samuel, Ke Zeng, Irene E Harmsen, et al.
Oncotarget|June 22, 2016
The metabolic/pH sensor soluble adenylyl cyclase is a tumor suppressor proteinLavoisier Ramos-Espiritu, Ana Diaz, Charlee Nardin, et al.
Dermatology Research and Practice|April 2, 2020
Long-Term Infliximab Treatment in Psoriasis Patients: A National Multicentre Retrospective StudyClémentine Carlet, Damien Bichard, Marie Aleth Richard, et al.
Nature Communications|March 20, 2025
Individualized non-invasive deep brain stimulation of the basal ganglia using transcranial ultrasound stimulationGhazaleh Darmani, Hamidreza Ramezanpour, Can Sarica, et al.
Neurotoxicity Research|January 27, 2025
Glioprotective Effects of Resveratrol Against Glutamate-Induced Cellular Dysfunction: The Role of Heme Oxygenase 1 PathwayAndré Quincozes-Santos, Larissa Daniele Bobermin, Ana Carolina Tramontina, et al.
European Journal of Cancer (Oxford, England : 1990)|September 28, 2022
An open label, non-randomised, phase IIIb study of trametinib in combination with dabrafenib in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: A subgroup analysis of patients with brain metastasesCaroline Dutriaux, Caroline Robert, Jean-Jacques Grob, et al.
Neural Plasticity|February 13, 2013
Treadmill exercise induces hippocampal astroglial alterations in ratsCaren Bernardi, Ana Carolina Tramontina, Patrícia Nardin, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2021
Efficacy, safety and factors associated with disease progression in patients with unresectable (stage III) or distant metastatic (stage IV) BRAF V600-mutant melanoma: An open label, non-randomized, phase IIIb study of trametinib in combination with dabrafenibPhilippe Saiag, Caroline Robert, Jean-Jacques Grob, et al.
Vaccine|February 14, 2024
The impact of time since SARS-Cov-2 vaccination, age, sex and comorbidities on COVID-19 outcome in hospitalized patients with SARS-CoV-2 infectionFrancesco Donato, Andrea Pilotto, Emanuele Focà, et al.
Pageof 101